House Energy & Commerce oversight subcommittee Chair Morgan Griffith (R-VA) told Inside Health Policy he has already offered to work with FDA on creating a safe pathway to bring cannabidiol (CBD) products to market, just days after the agency on Jan. 26 said that the current food and dietary supplement frameworks won’t work for CBD, much to the chagrin of cannabis and dietary supplement groups. FDA now is calling on Congress to set up a new regulatory pathway for...